Middle East and Africa Liposome Drug Delivery Market

BMI RD

Middle East and Africa Liposome Drug Delivery Market Forecast to 2027- COVID -19 Impact and Regional Analysis- by Product Type (Liposomal doxorubicin, Liposomal paclitaxel, Liposomal Amphotericin B, Others); Technology (Stealth liposome technology, Non- PEGylated liposome technology, DepoFoam Liposome Technology, Lysolipid Thermally Sensitive Liposome Technology); Application (Fungal diseases, Cancer therapy, pain management, Viral Vaccine), and Country

Pages: 125

Market Introduction

The Liposome are novel drug delivery system (NDDS), they are vesicular structures consisting of bilayers which form spontaneously when phospholipids are disappeared in water. They are microscopic vesicles in which an aqueous volume is entirely enclosed by a membrane composed of lipid bilayers.

Market Overview and Dynamics

The Middle East and Africa Liposome Drug Delivery market is expected to reach US$ 327.97 million by 2027 from US$ 162.83 million in 2019. The market is anticipated to grow with a CAGR of 9.3 % from 2019 to 2027. Increasing Prevalence of chronic diseases, increasing demand for non-invasive drug delivery system along with rising R&D expenditures by pharmaceutical companies are some of the driving force of the market. Whereas, high cost associated with development of Non-invasive drug delivery system is about to hinder the market growth during forecast period.

Key Market Segments

In The liposome drug delivery market is mainly segmented on the basis of products, technology and applications. The products are liposomal doxorubicin, liposomal Paclitaxel.  On basis of technology it is segmented as stealth liposome technology, Depofoam liposome technology and others. And the final segmentation is on the application such as its usage in cancer therapy, fungal diseases, and pain management.

Major Sources and Companies Listed

Some of the major primary and secondary sources for Liposome drug delivery market included in the report are Food and Drug Administration (FDA), World health Organization (WHO) and others.

Reasons to buy the report

·        To understand the Middle East and Africa liposome drug delivery market landscape and identify market segments that are most likely to guarantee a strong return

·        Stay ahead of the race by comprehending the ever-changing competitive landscape for Middle East and Africa liposome drug delivery market

·        Efficiently plan M&A and partnership deals in liposome drug delivery market by identifying market segments with the most promising probable sales

·        Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form Middle East and Africa liposome drug delivery market

·        Obtain market revenue forecast for market by various segments from 2019 to 2027 in Middle East and Africa region

MIDDLE EAST AND AFRICA LIPOSOME DRUG DELIVERY MARKET SEGMENTATION

By Product

·        Liposomal doxurubicin

·        Liposomal Paclitaxel

·        Liposomal Amphotericin B

·        Others

By Technology

·        Stealth liposome technology

·        Depofoam liposome technology

·        Non-PEGylated liposome Technology

·        Lysolipid thermally Sensitive Liposome Technology

By Application

•             Fungal diseases

·        Cancer therapy

·        Pain management

·        Viral vaccines

·        Photodynamic Therapy

By Country

·        South Africa

·        Saudi Arabia

·        UAE

Company Profiles

·        Takeda pharmaceutical company

·        Novartis AG

·        Ipsen pharma

·        Celsion Inc

·        Luye pharma group

Middle East and Africa Liposome Drug Delivery Market Strategic Insights

Middle East and Africa Liposome Drug Delivery Market Segmentation Analysis

Middle East and Africa Liposome Drug Delivery Market Report Highlights

Middle East and Africa Liposome Drug Delivery Report Scope

Middle East and Africa Liposome Drug Delivery Market Country and Regional Insights